GANX: Gain Therapeutics, Inc. Stock

by  •  • Comments Off on GANX: Gain Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 50.02
Enterprise Value ($M) 40.07
Book Value ($M) 7.34
Book Value / Share 0.26
Price / Book 6.81
NCAV ($M) 6.82
NCAV / Share 0.25
Price / NCAV 7.34

Profitability (mra)
Return on Invested Capital (ROIC) -2.55
Return on Assets (ROA) -1.40
Return on Equity (ROE) -2.36

Liquidity (mrq)
Quick Ratio 2.97
Current Ratio 2.97

Balance Sheet (mrq) ($M)
Current Assets 11.60
Assets 12.12
Liabilities 4.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -20.36
Net Income -20.41

Cash Flow Statement (mra) ($M)
Cash From Operations -18.87
Cash from Investing 4.98
Cash from Financing 13.01

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-16 30,789 170,878 18.02
2025-04-15 26,107 183,205 14.25
2025-04-14 124,024 488,990 25.36
2025-04-11 90,065 309,763 29.08

(click for more detail)

Similar Companies
FHTX – Foghorn Therapeutics Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc. GHRS – GH Research PLC
HRMY – Harmony Biosciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io